All articles tagged with #dementia with lewy bodies
Two large international studies have identified brain biomarkers using MRI that can predict whether individuals with REM sleep behavior disorder will develop Parkinson's disease or dementia with Lewy bodies years before symptoms appear, enabling earlier diagnosis and targeted interventions.
A new study suggests that drugs used to treat enlarged prostate, specifically terazosin, doxazosin, and alfuzosin, may reduce the risk of developing dementia with Lewy bodies (DLB) by boosting energy production in brain cells. This finding, which mirrors previous research linking these drugs to a protective effect in Parkinson's disease, indicates potential for broader use in managing neurodegenerative conditions. The study, however, is observational and only included men, so further research is needed to confirm these results.